semaglutide may 2025 Ozempic (semaglutide), a medication FDA-approved for type 2 diabetes and chronic weight management, is increasingly being discussed by people living with endometriosis. While not approved to treat the condition, we know that May 2024 vs July 2025

Nearly one-third of users said they wish they had known how common side effects would be before starting GLP-1s

Higher concentrations require smaller injection volumes, which can be more comfortable but require more precise measurement

The effects of antenatal smoking on lung function and respiratory symptoms in infants and children

Employer FAQs on the Rise of GLP-1 Drugs for Weight Loss and the Workplace Impact The rise of prescription medications used for weight loss has reshaped conversations about employer-sponsored health benefits and raised many new questions for employers

Initially, the researchers assessed the basic physiological parameters related to the diet